mottled hyperpigmentation

DBCOND0022269Clinical Procedures, Devices, and Diagnostic ActivitiesSigns, Symptoms, and General Pathologies

mottled hyperpigmentation is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Mottled pigmentation
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10L81.9SNOMED CT414032001MedDRA10035023UMLSC0549567

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in

Which approved drugs for mottled hyperpigmentation share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In